Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 3, 2008, Pages 452-459

  Karjagin, J ^a   Lefeuvre, S ^b,c   Oselin, K ^a   Kipper, K ^a   Marchand, S ^b,c   Tikkerberi, A ^a   Starkopf, J ^a   Couet, W ^b,c   Sawchuk, R J ^d  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE; FUROSEMIDE; MEROPENEM; NORADRENALIN; TORASEMIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICRODIALYSIS; MINIMUM INHIBITORY CONCENTRATION; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; SEPTIC SHOCK; STEADY STATE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; FEMALE; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; PERITONITIS; SHOCK, SEPTIC; THIENAMYCINS; TISSUE DISTRIBUTION;

EID: 39449096286     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100312     Document Type: Article

References (31)

1. Friedman, G., Silva, E. & Vincent, J.L. Has the mortality of septic shock changed with time? Crit. Care Med. 26, 2078-2086 (1998).
2. Barie, P.S., Hydo, L.J. & Eachempati, S.R. Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surg. Infect. 5, 365-373 (2004).
3. Annaya, D.A. & Nathens, A.B. Risk factors for severe sepsis in secondary peritonitis. Surg. Infect. 4, 355-362 (2003).
4. Billing, A., Frohlich, D. & Schildberg, F.W. Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group. Br. J. Surg. 81, 209-213 (1994).
5. Kirschner, M. Die Behandlung der akuten eitrigen freien Bauchfellentzuendung. Langenbecks Arch. Chir. 142, 53-267 (1926).
6. Kitzes-Cohen, R., Farin, D., Piva, G. & De Myttenaere-Bursztein, S.A. Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients. Int. J. Antimicrob. Agents 19, 105-110 (2002).
7. Lovering, A.M. et al. The pharmacokinetics of meropenem in surgical patients with moderate or severe infections. J. Antimicrob. Chemother. 36, 165-172 (1995).
8. Bedikian, A. et al. Pharmacokinetics of meropenem in patients with intra-abdominal infections. Antimicrob. Agents Chemother. 38, 151-154 (1994).
9. Condon, R.E. et al. Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery. Clin. Infect. Dis. 24(suppl. 2): S181-S183 (1997).
10. Gall, S. et al. Tissue penetration of meropenem in patients undergoing gynecologic surgery. Clin. Infect. Dis. 24(suppl. 2): S178-S180 (1997).
11. Brunner, M., Derendorf, H. & Muller, M. Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs. Curr. Opin. Pharmacol. 5, 495-499 (2005).
12. Joukhadar, C., Derendorf, H. & Müller, M. Microdialysis. A novel tool for studies of antiinfective agents. Eur. J. Clin. Pharmacol. 57, 209-217 (2001).
13. Tomaselli, F., Maier, A., Matzi, V., Smolle-Juttner, F.M. & Dittrich, P. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob. Agents Chemother. 48, 2228-2232 (2004).
14. Karjagin, J., Pahkla, R., Karki, T. & Starkopf, J. Distribution of metronidazole in muscle tissue of patients with septic shock and its efficacy against Bacteroides fragilis in vitro. J. Antimicrob. Chemother. 55, 341-346 (2005).
15. Korth, U. et al. Intestinal ischemia during cardiac arrest and resuscitation: comparative analysis of extracellular metabolites by microdialysis. Resuscitation 58, 209-217 (2003).
16. Tenhunen, J., Kosunen, H., Alhava, E., Tuomisto, L. & Takala, J. Intestinal luminal microdialysis. Anesthesiology 91, 1807-1815 (1999).
17. Bahlmann, L. et al. Microdialysis as a procedure for evaluating intestinal hypoxia - an animal experiment approach. Biomed. Technol. 48, 27-30 (2003).
18. Klaus, S. et al. Continuous biochemical tissue monitoring during acute hypoxia. Anaesthesiol. Reanim. 28, 104-109 (2003).
19. Jansson, K. et al. Postoperative on-line monitoring with intraperitoneal microdialysis is a sensitive method for measuring increased anaerobic metabolism that correlates to the cytokine response. Scand. J. Gastroenterol. 39, 434-439 (2004).
20. Lefeuvre, S., Marchand, S., Lamarche, I., Mimoz, O. & Couet, W. Microdialysis study of imipenem distribution in the intraperitoneal fluid of rats with or without experimental peritonitis. Antimicrob. Agents Chemother. 50, 34-37 (2006).
21. Novelli, A. et al. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis. Clin. Pharmacokinet. 44, 539-549 (2005).
22. Rowland, M. & Tozer, T.N. Clinical Pharmacokinetics: Concepts and Applications 3rd edn. (Williams & Wilkins, Baltimore, MD, 1995 ).
23. Takala, J. Determinants of splanchnic blood flow. Br. J. Anaesth. 77, 50-58 (1997).
24. Ruokonen, E. et al. Regional blood flow and oxygen transport in septic shock. Crit. Care Med. 21, 1296-1303 (1993).
25. Robatel, C. et al. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J. Clin. Pharmacol. 43, 1329 (2003).
26. Bonfiglio, G., Russo, G. & Nicoletti, G. Recent developments in carbapenems. Expert Opin. Investig. Drugs 11, 529-544 (2002).
27. Mouton, J.W., Touzw, D.J., Horrevorts, A.M. & Vinks, A.A. Comparative pharmacokinetics of the carbapenems: clinical implications. Clin. Pharmacokinet. 39, 185-201 (2000).
28. Bone, R.C. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655 (1992).
29. Ståhle, L., Segersvärd, S. & Ungerstedt, U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J. Pharmacol. Methods 25, 41-52 (1991).
30. Carlucci, G., Biordi, L., Vicentini, C. & Bologna, M. Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 8, 283-286 (1990).
31. Anonymous. Performance Standards for Antimicrobial Susceptibility Testing; Approved Standard 9th edn. (CLSI, Wayne, PA, 2006).